{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:45:21Z","timestamp":1791312321121,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jconrel.2025.114541","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:17:26Z","timestamp":1765556246000},"page":"114541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Enhancing nanomedicine efficacy in KPC pancreatic tumors through ketotifen-mediated tumor microenvironment remodeling"],"prefix":"10.1016","volume":"390","author":[{"given":"Antonia","family":"Charalambous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Mpekris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysovalantis","family":"Voutouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Neophytou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Djamus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gabizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triantafyllos","family":"Stylianopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114541_bb0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies","volume":"2","author":"Chauhan","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.jconrel.2025.114541_bb0010","doi-asserted-by":"crossref","first-page":"1564626","DOI":"10.3389\/fcell.2025.1564626","article-title":"The mechanopathology of the tumor microenvironment: detection techniques, molecular mechanisms and therapeutic opportunities","volume":"13","author":"Angeli","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2025.114541_bb0015","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","article-title":"Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse","volume":"73","author":"Stylianopoulos","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114541_bb0020","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1073\/pnas.1213353109","article-title":"Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors","volume":"109","author":"Stylianopoulos","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114541_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","article-title":"The role of mechanical forces in tumor growth and therapy","volume":"16","author":"Jain","year":"2014","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114541_bb0030","first-page":"937","article-title":"Beyond matrix stiffness: targeting force-induced cancer drug resistance, trends","volume":"9","author":"Kalli","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.114541_bb0035","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s42003-024-07268-1","article-title":"Mechanical forces inducing oxaliplatin resistance in pancreatic cancer can be targeted by autophagy inhibition","volume":"7","author":"Kalli","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jconrel.2025.114541_bb0040","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","article-title":"Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer","volume":"184","author":"Raghavan","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114541_bb0045","article-title":"Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy","volume":"5","author":"Mpekris","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jconrel.2025.114541_bb0050","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.nano.2015.07.015","article-title":"Design considerations for nanotherapeutics in oncology","volume":"11","author":"Stylianopoulos","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.114541_bb0055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/d41587-019-00019-2","article-title":"Pancreatic cancer provides testbed for first mechanotherapeutics","volume":"37","author":"Sheridan","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114541_bb0060","doi-asserted-by":"crossref","first-page":"24506","DOI":"10.18632\/oncotarget.15534","article-title":"Pirfenidone normalizes the tumor microenvironment to improve chemotherapy","volume":"8","author":"Polydorou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2025.114541_bb0065","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.neo.2016.10.001","article-title":"Hyaluronan-derived swelling of solid tumors, the contribution of collagen and Cancer cells, and implications for Cancer therapy","volume":"18","author":"Voutouri","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2025.114541_bb0070","doi-asserted-by":"crossref","first-page":"46140","DOI":"10.1038\/srep46140","article-title":"Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner","volume":"7","author":"Papageorgis","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114541_bb0075","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1158\/1078-0432.CCR-24-0246","article-title":"Stabilizing tumor-resident mast cells restores T-cell infiltration and sensitizes sarcomas to PD-L1 inhibition","volume":"30","author":"Panagi","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114541_bb0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2022.03.008","article-title":"Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy","volume":"345","author":"Mpekris","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114541_bb0085","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114541_bb0090","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1158\/1535-7163.MCT-23-0772","article-title":"Tumor microenvironment reprogramming improves nanomedicine-based chemo-immunotherapy in sarcomas","volume":"23","author":"Charalambous","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2025.114541_bb0095","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","article-title":"Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial","volume":"5","author":"Murphy","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2025.114541_bb0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114541_bb0105","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.20.00590","article-title":"Randomized phase III trial of Pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with Hyaluronan-high metastatic pancreatic adenocarcinoma","volume":"38","author":"Van Cutsem","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114541_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.100990","article-title":"A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas","volume":"51","author":"Mpekris","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2025.114541_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113722","article-title":"Sonopermeation combined with stroma normalization enables complete cure using nano-immunotherapy in murine breast tumors","volume":"382","author":"Neophytou","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114541_bb0120","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/1061186X.2016.1191081","article-title":"Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer","volume":"24","author":"Shmeeda","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2025.114541_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.2","article-title":"Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D\/+); LSL-Trp53(R172H\/+); Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery","volume":"73","author":"Lee","year":"2016","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.jconrel.2025.114541_bb0130","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114541_bb0135","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114541_bb0140","doi-asserted-by":"crossref","first-page":"32654","DOI":"10.1021\/acsnano.5c10301","article-title":"Ultrasound-mediated Piezocatalysis triggers NO release to augment targeted immunotherapy of pancreatic Cancer","volume":"19","author":"Song","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114541_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114143","article-title":"Gut microbial diversity is preserved through localised chemo-immunotherapy delivery in a KPC mouse model of pancreatic cancer","volume":"386","author":"Minaei","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114541_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091309","article-title":"Pegylated liposomal alendronate biodistribution, immune modulation, and tumor growth inhibition in a murine melanoma model","volume":"13","author":"Islam","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2025.114541_bb0155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.7150\/ntno.75045","article-title":"Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model","volume":"6","author":"Islam","year":"2022","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.jconrel.2025.114541_bb0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2017.12.023","article-title":"Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate","volume":"271","author":"Rajan","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114541_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semcancer.2019.12.001","article-title":"Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment","volume":"68","author":"La-Beck","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2025.114541_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2010.09.003","article-title":"Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects","volume":"63","author":"Maruyama","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114541_bb0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jim.2012.06.005","article-title":"Area under the curve as a tool to measure kinetics of tumor growth in experimental animals","volume":"382","author":"Duan","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2025.114541_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114541_bb0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114541_bb0190","doi-asserted-by":"crossref","first-page":"24654","DOI":"10.1021\/acsnano.3c03305","article-title":"Pirfenidone-loaded polymeric micelles as an effective Mechanotherapeutic to potentiate immunotherapy in mouse tumor models","volume":"17","author":"Mpekris","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114541_bb0195","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-011-8262-6","article-title":"Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy","volume":"51","author":"Sato","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.114541_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114541_bb0205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.jconrel.2025.114541_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061433","article-title":"An update on the molecular basis of Phosphoantigen recognition by Vgamma9Vdelta2 T cells","volume":"9","author":"Herrmann","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.114541_bb0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2165\/00003495-199040030-00006","article-title":"A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders","volume":"40","author":"Grant","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2025.114541_bb0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-2736(92)90084-Y","article-title":"In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release","volume":"1109","author":"Horowitz","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2025.114541_bb0225","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1038\/s41598-024-56706-x","article-title":"Evaluation metrics and statistical tests for machine learning","volume":"14","author":"Rainio","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114541_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/computation13050127","article-title":"Assessing the validity of k-fold cross-validation for model selection: evidence from bankruptcy prediction using random Forest and XGBoost","volume":"13","author":"Teodorescu","year":"2025","journal-title":"Computation"},{"key":"10.1016\/j.jconrel.2025.114541_bb0235","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.220232","article-title":"A guide to cross-validation for artificial intelligence in medical imaging","volume":"5","author":"Bradshaw","year":"2023","journal-title":"Radiol Artif Intell"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:22:10Z","timestamp":1781702530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0168365925011551"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114541","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing nanomedicine efficacy in KPC pancreatic tumors through ketotifen-mediated tumor microenvironment remodeling","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114541"}}